Aeonian Biotech's mission is to eradicate wasted R&D expenses caused by poorly characterised, unstable, inconsistently performing, or no longer available immunological reagents. Among the large amounts of commercially available antibodies to any one specific protein/biomarker, They identify those few that meet the highest quality standards. The information on the manufacturer’s product sheet is thoroughly scrutinised. Using proprietary selection criteria they identify the best candidate antibodies.